Growth Metrics

Nu-Med Plus (NUMD) Shareholder's Equity Growth (1y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nu-Med Plus - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -26.12%
Sep 30, 2025 -26.46%
Jun 30, 2025 -32.73%
Mar 31, 2025 -39.42%
Dec 31, 2024 -46.57%
Sep 30, 2024 -55.01%
Jun 30, 2024 -60.85%
Mar 31, 2024 -84.78%
Dec 31, 2023 -132.85%
Sep 30, 2023 51.15%
Jun 30, 2023 53.23%
Mar 31, 2023 51.73%
Dec 31, 2022 52.38%
Sep 30, 2022 -285.81%
Jun 30, 2022 -14,865.54%
Mar 31, 2022 -198.98%
Dec 31, 2021 -128.30%
Sep 30, 2021 -131.59%
Jun 30, 2021 -100.40%
Mar 31, 2021 151.99%
Dec 31, 2020 226.26%
Sep 30, 2020 173.06%
Jun 30, 2020 233.96%
Mar 31, 2020 -63.50%
Dec 31, 2019 -863.35%
Sep 30, 2019 -256.01%
Jun 30, 2019 -1,137.48%
Mar 31, 2019 -968.63%
Dec 31, 2018 -28.89%
Sep 30, 2018 332.43%
Jun 30, 2018 74.40%
Mar 31, 2018 42.64%
Dec 31, 2017 101.54%
Sep 30, 2017 132.92%
Jun 30, 2017 -116.79%
Mar 31, 2017 85.56%
Dec 31, 2016 70.84%
Sep 30, 2016 36.76%
Jun 30, 2016 412.39%
Mar 31, 2016 -44.24%
Dec 31, 2015 -114.05%
Sep 30, 2015 -301.75%
Jun 30, 2015 -165.02%
Mar 31, 2015 -172.09%
Dec 31, 2014 -5,620.00%
Sep 30, 2014 63.10%
Jun 30, 2014 272.49%
Mar 31, 2014 289.57%
Dec 31, 2013 -169.81%
Dec 31, 2012 -15,574.83%